Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal-cell carcinoma after radical nephrectomy: phase III, randomised controlled trial-Reference-Cited by-同舟云学术

Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal-cell carcinoma after radical nephrectomy: phase III, randomised controlled trial

Published:2004-02 Issue:9409 Volume:363 Page:594-599
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Jocham Dieter,Richter Axel,Hoffmann Lothar,Iwig Klaus,Fahlenkamp Dirk,Zakrzewski Günther,Schmitt Eberhard,Dannenberg Thomas,Lehmacher Walter,von Wietersheim Jörn,Doehn Christian

Publisher

Elsevier BV

Subject

General Medicine

Reference31 articles.

1. Renal cell carcinoma: management of advanced disease;Figlin;JUrol,1999

2. Cancer statistics, 2003;Jemal;CA Cancer J Clin,2003

3. TNM atlas: Illustrierter Leitfaden zur TNMpTNM-Klassifikation maligner Tumoren;Spiessl,1993

4. Prognostic factors in renal cell carcinoma;Dal Bianco;Eur Urol,1988

5. Analysis of imaging modalities, staging systems, and prognostic indicators for renal cell carcinoma;Dinney;Urology,1992

Cited by 364 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adjuvant immunotherapy for locally advanced renal cell carcinoma;Expert Opinion on Biological Therapy;2023-12-02

2. Adjuvant therapy for renal cell carcinoma: A systematic review of current landscape and future directions;Critical Reviews in Oncology/Hematology;2023-12

3. Non‐coding RNAs in cancer immunotherapy: Predictive biomarkers and targets;Clinical and Translational Medicine;2023-09

4. Cancer immunotherapies: advances and bottlenecks;Frontiers in Immunology;2023-08-24

5. Efficacy of Therapy vs Surveillance in Patients with Resected Early-Stage Intermediate to High-Risk Renal Cell Carcinoma;Kidney Cancer;2023-05-26